Evidence map›Paper›PMID 40076339›Full record

ArticleMolecules (Basel, Switzerland)2025

De Novo Design of Large Polypeptides Using a Lightweight Diffusion Model Integrating LSTM and Attention Mechanism Under Per-Residue Secondary Structure Constraints.

Sisheng Liao, Gang Xu, Li Jin, Jianpeng Ma

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. SegDesign: A modular framework for controllable protein segment engineering.Protein science : a publication of the Protein Society · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sisheng LiaoSchool of Life Sciences, Fudan University, Shanghai 200433, China.ORCID 0009-0000-6987-4564
Gang XuMultiscale Research Institute of Complex Systems, Fudan University, Shanghai 200433, China.
Li JinSchool of Life Sciences, Fudan University, Shanghai 200433, China.
Jianpeng MaMultiscale Research Institute of Complex Systems, Fudan University, Shanghai 200433, China.

Funding

National Natural Science Foundation of China No. 32300535Research Fund for International Senior Scientists No. W2431060Science and Technology Innovation Plan of Shanghai Science and Technology Commission No. 23JS1400200
6 · The paper itself

Abstract

This study presents PolypeptideDesigner (PPD), a novel conditional diffusion-based model for de novo polypeptide sequence design and generation based on per-residue secondary structure conditions. By integrating a lightweight LSTM-attention neural network as the denoiser within a diffusion framework, PPD offers an innovative and efficient approach to polypeptide generation. Evaluations demonstrate that the PPD model can generate diverse and novel polypeptide sequences across various testing conditions, achieving high pLDDT scores when folded by ESMFold. In comparison to the ProteinDiffusionGenerator B (PDG-B) model, a relevant benchmark in the field, PPD exhibits the ability to produce longer and more diverse polypeptide sequences. This improvement is attributed to PPD's optimized architecture and expanded training dataset, which enhance its understanding of protein structural pattern. The PPD model shows significant potential for optimizing functional polypeptides with known structures, paving the way for advancements in biomaterial design. Future work will focus on further refining the model and exploring its broader applications in polypeptide engineering.

Indexed as

PeptidesAlgorithmsAmino Acid SequenceDiffusionModels, MolecularNeural Networks, ComputerProtein FoldingProtein Structure, SecondaryPeptidesattention mechanismDDPMdeep learninglong short-term memory networks (LSTM)neural networkprotein designtext generation models

Identifiers

PMID40076339
PMCPMC11902264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.